Register today to unlock Valuecruncher

Choose a username
Your email address
Choose a password
Confirm password
Choose your membership
1 year account US$89 US$49
Lifetime account US$299 US$199
Name on card *
Credit card number *
Credit card expiry *
or Cancel
Our terms & conditions and privacy policy

Unlimited access to all companies
Save your own valuations
Comparison + DCF analysis for S&P500, FTSE350 and others

If you have already registered, please login

United Therapeutics Corporation (UTHR)

Register today to unlock Valuecruncher and get unlimited access

Get unlimited access to all compartors and data
Save and share valuations as well as comment on others
Alter and save your favourite comparator companies

Already registered? Please login now

Dollar

Point

Implied share price

Buy Undervalued by 73.7%

5% margin of safety What's this?

EV / EBITDA Use Average	UTHR United Therapeutics Corporation	SNY Sanofi SA (ADR) Change	DNA Genentech, Inc. Change	GILD Gilead Sciences, Inc. Change	AMGN Amgen, Inc. Change
12.66	7.1	6.46	17.08	21.38	9.0
All amounts in millions from last financial year
Implied Share Price	$118.94	$112.73	$71.23	$31.42	$148.38
Market Cap	3,400	145,031	100,042	85,313	78,395
Net Debt	-204	8,094	-3,369	6,361	2,468
Enterprise Value (EV)	3,199	80,290	96,673	91,674	80,863
Revenue	916	35,957	13,418	9,702	17,265
EBITDA	450	12,422	5,661	4,288	8,985
Percent	49.2 %	34.5 %	42.2 %	44.2 %	52.0 %
EBIT	421	7,825	5,069	4,010	7,500
Percent	46.0 %	21.8 %	37.8 %	41.3 %	43.4 %
Balance Sheet
Total Assets	1,626	100,407	21,787	21,239	54,298
Total Liabilities	531	43,069	6,116	11,930	35,238
Shareholders Equity	1,094	57,338	15,671	9,309	19,060.0

Comments

No comments yet. Login to comment.